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Abstract 
 
Infrastructure is widely regarded merely as a material (lifeless) system that brings together the activities 
of diverse practices. In contrast to this view, we propose that when infrastructure provides a site where 
practices are held at once both near and apart, life under the influence of these practices is ‘lived to the 
full’. We call the resultant whole ‘living infrastructure’ to denote that it is both infrastructure for living 
and infrastructure that ‘lives’. The key idea is that a living infrastructure becomes the site where an 
opening between certain regions of life, that share some concern, happens. We will argue that such 
infrastructure is an on-going achievement of becoming, which requires nurturing and vigilance to 
produce and its continued productivity: otherwise it will cease to ‘live’. We present an empirical case 
from the German healthcare environment - the Federal Unified Medication Plan for medication therapy 
safety. We argue in detail that this is a nascent living infrastructure providing a site where a productive 
opening ‘happens’ between multiple practices involved in medication therapy safety. We analyse this 
‘happening’ to establish how this opening took hold, how it was kept open, and how it was kept 
productive.  
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Introduction 
Infrastructure is widely regarded as a material system that coordinates the activities of diverse practices. 
On one view, the ideal for infrastructure is to mechanise sanctioned forms of interaction between 
practices pursuing different and often conflicting goals, such that the resulting whole forms a well-oiled 
machine operating under a negotiated highest common denominator (Edwards, 2010). On another view, 
infrastructure should become an un-noticed lowest common denominator, on the basis of which diverse 
practices draw meaning and support, but get out of each other’s way and act as independently as possible 
(Hanseth and Lyytinen, 2010). 
In this essay, we argue against the notion that infrastructure is a material enabler of either a tight or 
loose coupling of activities of diverse practices. Instead, we propose that when infrastructure provides 
a site for an ‘opening’ in which practices are held at once both near and apart - both already familiar 
and not yet familiar, both same and other, both resisting and accommodating - life under the influence 
of these practices is lived to the full. We call the resultant whole ‘living infrastructure’ to denote that it 
is both infrastructure for living and infrastructure that ‘lives’1. We will argue that such infrastructure is 
an on-going achievement of becoming2, which requires nurturing to maintain its continued productivity, 
and vigilance against the three-fold threats of tokenization, colonization and mechanization: otherwise 
it will cease to ‘live’. 
First we present the Medieval European City Square as a motivating example of a living infrastructure. 
We will employ this exemplar to define the conceptual parts which together we take to constitute ‘living 
infrastructure’. Next we introduce a contemporary empirical case from the German healthcare 
environment. This is the Federal Unified Medication Plan for medication therapy safety. We argue in 
detail that this is a nascent living infrastructure providing a site where a productive opening ‘happens’ 
between multiple practices involved in medication therapy safety. We analyse this ‘happening’ to 
further refine the notion of living infrastructure, by establishing how this opening took hold, how it was 
kept open, and how it was kept productive. We conclude by briefly contrasting living infrastructure 
with the traditional view. 
Conceptual Preliminaries 
Our aim in this section is to provide an initial conceptual framework for discussing living infrastructure 
and the terminology we will employ in the remainder of the paper.  
The Medieval City Square 
The city square arose as an important part of the Medieval European city layout and provided an open 
area in which city inhabitants could conduct the various aspects of their daily public lives. Frequently, 
city squares arose around a public water-well that became their centre piece, and on their sides stood 
various institutional buildings - for instance a church, a market, the town hall, a school - that made 
available to the inhabitants important influences on the conduct of a rich city life - such as religion, 
commerce, government and culture. 
The city square thus established the presence of different ‘regions’ of public city life to the inhabitants, 
but importantly, it also held regions with a natural antipathy (such and the spiritual and the corporal, or 
the personal and the social) apart. The geography of the square quite literally protects life in the square 
from domination by any one region of city life, by placing its institutional representatives on different 
bounding sides of the square. 
We suggest that the medieval square provides a conceptual exemplar for living infrastructure – in this 
case infrastructure for public city life to be lived to the full. The city square arises as an opening in the 
clutter of the city; it is maintained as an opening in city life because regions of that life are established 
                                                      
1 Hubert Dreyfus (2017) would say, in the same vein, that it ‘shines’. See also Heidegger (1950/1971, p180) 
2 In other words, a process in the strong sense (Tsoukas and Chia, 2002; Langley et al, 2013) 
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as both present and distinct by its layout; and it is productive of a good life because it encourages a 
continual encounter and evaluation of the ‘regions’ of city life in the course of daily interaction, and 
thus a continual on-going evaluation of what a good city life could be. In the opening of the city square, 
the contrasting regions of life are established as regions, and a good city life lived in the presence of 
these regions is disclosed to those who dwell there.  
The City Square as Living Infrastructure 
In what follows we will draw on the city square exemplar to give an account of how infrastructure more 
generally can ‘live’ when it provides the site where such a productive opening can take hold. It ‘lives’ 
when such an opening ‘happens’, and this happening3 is living life to the full. However, first must take 
some care to point out in what respects the example instantiates ‘a productive opening’ as we see it, and 
what aspects of the example might lead the reader astray. 
Firstly, it is not the square as a material entity creating an open physical space in the city, nor the 
geography of the square mediating the opposition of the institutional buildings, that we wish to identify 
with such an opening. That is, here we are not interested in the usual conception of infrastructure as a 
material structure that coordinates diverse activities. Secondly, we are not interested in the square as a 
politically negotiated creation of the institutions to demarcate their various territories in their subjects’ 
lives. That is, we are not treating infrastructure as an outcome of social negotiation between ‘stake 
holders’ in city living. 
Rather, we view the city square as making possible particular lived interactions of the city dwellers that 
already happen under the aegis of these institutions. Thus, the square as a built place is merely the ‘site’ 
where certain oppositions – of nearness and farness – among the ‘regions’ of the overall concern of the 
square (that is, a good city life) already lived there, are made possible. By connecting and opposing the 
institutions that embody these regions of life in the built place, the opening that the square grounds 
establishes them as distinct regions of the life lived there. What is productive about the city square is 
not its spatial or institutional geography but the distinction-making function of its openness. It is the 
openness of the square - not the square as such - that we view as the ‘opening’. The common concern 
enacted in the square, the regions of life founded by the square, the openness of the square, the square 
as the site of this opening, and the happening of this openness, are what together constitute living 
infrastructure (see Table 1).  
Table 1. Conceptual parts that constitute living infrastructure 
 
Concept Definition Example (City Square) 
Concern A concern defines that aspect of human 
existence with which the infrastructure deals 
The concern is living a good life in a city 
Region Regions are distinct aspects of the concern – 
they are distinct ‘locations on a map’ of the 
concern.  
The regions are the institutions of town life – 
religion, state, commerce, and 
education/culture 
Opening An opening is the establishment of 
productive distinctions between the regions 
of the concern 
The establishment of distinctions between 
spiritual, corporal, individual and social 
aspects of a good city life 
Site of an opening Where a productive opening takes hold The lived-in city square that provides the 
conditions of an opening between church, 
town hall, market and school to happen 
The happening of an 
opening 
How an opening takes hold, is kept open, 
and continues to be productive  
For any particular city square this could only 
be uncovered by detailed historical 
scholarship 
Thus, facilitating a good city life is not simply a matter of building a square that coordinates or controls 
access to the separate, opposing institutions of life. Nor is it a matter of regulating the real estate of the 
square to prevent institutional encroachment on the political balance of city life. Rather, it is a matter 
                                                      
3 We use ‘happening’ in line with Heidegger’s notion of Ereignis (Polt, 2005) – a productive, dialectical, gathering event (in 
the extended sense of event).  
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of creating the conditions under which a square as a region-defining opening can arise, be kept open, 
and can continue to be productive. Only then can the square become infrastructure that ‘lives’. The 
nature of an opening that makes this happen is the issue that we take up in the remainder of the paper.  
We have not created these ideas ex nihilo: our conception of the city square as a productive opening has 
been inspired by our reading of various works from the later philosophical period of Martin Heidegger, 
in particular the essays “Building, Dwelling, Thinking”, “The Thing” and “The Origin of the Work of 
Art” (Heidegger, 1971). 
Case Background 
Thanks to advances in general living conditions as well as the medical sciences, people now live much 
longer but also tend to live with chronic and multiple diseases when they are old, a condition known as 
multi-morbidity. This condition, in turn, is associated with the continuous use of a cocktail of drugs, 
so-called poly-pharmacy. Healthcare systems in most developed countries, however, have been erected 
on the assumption that people fall ill only occasionally and then, for a limited time, use a drug targeted 
specifically at that illness. Healthcare systems are generally not equipped to cope with monitoring and 
continuously adapting medication regimes of multiple drugs taken over long periods. This often results 
in combinations of drugs which are ineffective, due to cancellation of their effects, or risky, if effects 
of drugs amplify one another in unanticipated ways. 
In Germany, the term ‘medication therapy safety’ was coined for this issue as part of a national action 
plan published by the Ministry of Health in 2007. This ‘National Action Plan for the Improvement of 
Medication Therapy Safety’ has since been updated three more times with the current action plan 
covering the period 2016-2019. These plans are supported by a ‘Coordination Group on Implementing 
and Updating the Action Plan for Improving Medication Therapy Safety’, in the following just 
‘Coordination Group’. This group has met regularly about three times per year since the publication of 
the first action plan. The group comprises representatives of various national-level professional 
associations, the Ministry of Health, and patient groups. Initially, it was mostly physicians, as well as 
community and hospital pharmacists, who participated in the meetings as professional specialists. Later, 
members of a national nursing association, the national hospital association, and the federal association 
of panel doctors – concerned with administering the reimbursement of doctors – officially joined the 
group. 
The structure of the various action plans has remained relatively stable over the years. Sections outline 
establishing awareness of the problem of medication therapy safety both among medical professionals 
and patients, creating a ‘safety culture’, and various more specific measures such as encouraging 
physicians to report side effects to a national registry, with each attracting funds from the Ministry of 
Health by competitive tendering. The implementation of some of these measures is the responsibility 
of the Coordination Group itself, including a project to design and distribute an information flyer for 
patients to increase awareness for the problem and to establish a safety culture. One idea was to include 
the template for a ‘medication plan’ in this flyer so that patients could create their own medication 
plans. 
However, over time this idea took on larger proportions; the group began to discuss what is now called 
the ‘Federal Unified Medication Plan’ (‘Medication Plan’ in the following) as an information and 
communication tool for all those involved in the medication process. Eventually, the Medication Plan 
became part of a new law, the so-called e-health law, published in December 2015, obliging physicians 
from October 2016 to create and print out a medication plan for patients who regularly take three or 
more drugs. From April 2017, such medication plans must comply with a detailed specification of the 
Medication Plan. This includes a 2D barcode so that a patient’s medication plan can be machine-read 
and updated. How this Medication Plan came to productively structure interactions among the practices 
of the Coordination Group is the focus of our case. 
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Case Materials 
We draw on two kinds of empirical material. Our main source for reconstructing and interpreting the 
story of the Medication Plan is the published meeting minutes of the Coordination Group. Since the 
publication of the first action plan in 2007, the group has met 30 times. All 29 publically available 
meeting minutes were first read from last to first by one of the authors and then, in the reverse order, 
excerpted and summarized into four categories: (1) composition of the group; (2) discussions 
concerning the definition of medication therapy safety; (3) discussions concerning the medication plan; 
(4) other relevant aspects of the discussion. 
The second empirical source is the experiences of one of the authors as a founder of the ‘Aachen 
Learning Community on Innovative Use of IT in Drug Distribution’ (Claßen et al., 2015), a group of 
healthcare practitioners that has met about twice per year since February 2012 and which mirrors the 
composition and concerns of the Coordination Group, albeit at the local level. Recently, this group has 
started a project to document and reflect on experiences of physicians, pharmacists, and patients with 
the Medication Plan through an ongoing series of reflective video conversations. Apart from using 
domain specific knowledge from one of the author’s active participation in the discussions and activities 
of the Aachen Learning Community, we will also draw on findings from the first series of reflective 
video conversations. 
Case Findings 
In this section, we describe and interpret the story of the Medication Plan. The development of this case 
narrative has also contributed to developing the notion of living infrastructure as the happening of an 
opening and therefore serves to illuminate rather than just illustrate our basic concepts. The story of the 
Medication Plan thus serves a similar function to our city square example, namely, as an archetype of 
a general principle. While the city square metaphor was useful for deriving the basic concepts as defined 
in Table 1, the concrete contours of the happening of an opening could only be fleshed out through 
detailed historical analysis of a particular case. This led us to distinguish three issues that together reveal 
the happening of an opening: 
1. How the opening took hold, 
2. How the opening was kept open, 
3. How the opening was kept productive. 
While it would be tempting to associate these issues with distinct phases in a linear development 
process, we will argue later that they are better understood as constitutive parts of the happening of an 
opening. Thus, in each sub-section below, we present an episode particularly appropriate to each issue 
and do not intend these to be read as chronological.  
How the Opening Took Hold 
In this section, we will document how the various practices making up the Coordination Group came 
to encounter each other in a way that opened up the possibility of talking about and probing into new 
ways, not entirely managed and controlled by physicians, for determining and adjusting the medication 
therapy of patients. Out of this re-orienting of the dialogue between practices arose the Medication Plan 
which, in turn, became a site for re-orienting the relationships between the practices, initially those of 
physicians and pharmacists, but later also of regulators and patients. 
Traditionally, the relationship between physician and pharmacist is perceived to be asymmetrical, 
although that was not always the case (Schmitz, 1998). Accordingly, the pharmacist is supposed to 
merely follow the prescription written by the physician, dispensing the specific drug intended by the 
physician to the patient. Only in cases when a certain drug may threaten the life of a patient is the 
pharmacist expected and obliged to intervene in the physician’s medication decision by refusing to 
dispense that drug. In addition, the pharmacist is supposed to look out for possible unintended 
prescribing errors, for example where the names of two drugs are very similar. As these are exceptional 
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situations, it is not customary for the pharmacist to seek to communicate with the prescribing physician 
and physicians tend to evade direct conversation with pharmacists about the medication of a particular 
patient. 
This separation between the two practices is reflected in the institutional structure of the German 
healthcare system which has very few platforms where physicians and pharmacists are able to interact 
as professionals. To the extent that such institutionalized forums for the interaction exist, these are 
typically concerned with allocating resources and workloads but not with medication. The constitution 
of the Coordination Group was therefore an unlikely gathering because the participating practices, 
especially those of physicians and pharmacists, could come together under the aegis of a shared 
professional concern, namely medication therapy safety. 
The idea of the Medication Plan evolved from an addendum to an information flyer for patients, into 
an information and communication tool for all actors involved in medication. As such, the Medication 
Plan announces the possibility of more intense and frequent communication and cooperation between 
the various practices, in contrast to the then current one-directional information flow from physicians 
to patients, pharmacists, and nurses and relatives. However, the potential shift in how these various 
practices might be re-oriented through the Medication Plan was not explicitly discussed by the 
Coordination Group. Rather, discussions were about whether the information flyer should include a 
‘unified’ medication plan as a template for patients or not. Physicians were initially opposed to that 
idea, arguing that patients should design a medication plan according to their needs.  
The possibility that the medication plan might become a new information tool for all those involved in 
medication decisions marked a significant broadening of its purpose, here signified by our capitalization 
of the medication plan as ‘Medication Plan’. Such a possibility was explicitly announced in the second 
ministerial action plan, published immediately after the group’s eighth meeting. The second action plan 
also specified a measure to hold a workshop with software providers to ‘implement’ the Medication 
Plan in software systems for general physicians, community pharmacists, and hospitals. Thus, there was 
a clear intention to broaden the reach of the medication plan from an information tool for patients to 
these other practices, which would allow them to become involved in novel ways in medication 
processes. The action plan justified this new position by referring to the discussions in the Coordination 
Group; however, prior to the publication of the second action plan these discussions only referred to 
the medication plan as an addendum to the information flyer. 
Even though there are no indications in the meeting minutes that the Coordination Group explicitly 
discussed using the Medication Plan for re-orienting the various practices, there must have been an 
openness for this possibility. Otherwise, the action plan could not have referred to these discussions to 
justify the idea that the medication plan was to become a new information tool for all practices involved 
in medication processes, since that implies a significant shift from current practice using the prescription 
as a one-directional information tool. It appears that another discussion, which occurred concurrently 
with the discussions of the Medication Plan, greatly contributed to creating this openness, namely, a 
discussion concerning the definition of key terms related to medication therapy safety. One important 
aspect of that discussion was a proposal to distinguish between ‘undesired drug effects’ and ‘undesired 
drug events’. While undesired biochemical drug effects cannot be avoided, some undesired drug events 
can be avoided, for example, by changing the way or the time that a certain drug is taken. Making this 
distinction turned out to be important. For example, in one session the group had queried the federal 
association of physicians about whether the current education of physicians sufficiently addressed 
medication therapy safety. The association had replied in the affirmative, arguing that the topic of 
pharmacovigilance is firmly established in medical curricula. Pharmacovigilance, however, only 
addresses undesired drug effects but not undesired drug events, such as interactions between various 
drugs. The group therefore decided that there was a need to educate physicians about the difference 
between pharmacovigilance and medication therapy safety. 
The distinction between undesired drug effects and events opened the possibility for a legitimate and 
substantial involvement of pharmacists in medication decisions. Pharmacists are recognized to be 
‘experts in drugs’ and could therefore better fine-tune a certain drug regime to make sure that avoidable 
undesired drug events are indeed avoided: as long as only undesired drug effects (colloquially known 
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as ‘side effects’) mattered, it was clear that only physicians should make medication decisions because 
only they could trade-off side effects against intended effects.4 
We interpret these events as indicative of an opening taking hold. Initially, only a certain openness to 
an as-yet unspecified possibility of a new way of orienting the various practices is noticeable. This 
openness is manifest in both the readiness to see the Medication Plan as something more substantial 
than was initially envisaged, and in the making of the distinction between undesired drug events and 
effects. Both these manifestations announce the possibility of a more significant involvement of 
pharmacists and other practices in medication processes which, however, was not yet specified or even 
thematised. Yet, following the publication of the second action plan, the Medication Plan would become 
the main site for working out these new roles, which came to concern the relationship between patient 
and regulatory practices in addition to pharmacists and physicians. Thus, the ‘taking hold’ of the 
opening involved the anticipation of a possibility that had yet to be worked out and defined. 
How the Opening was Kept Open 
In this section, we will describe (1) how, in the discussions within the Coordination Group, various 
efforts to ‘appropriate’ the medication plan by particular practices involved were fended off, and (2) 
how this keeping at bay contributed to working out the emerging re-orienting of relationships among 
these practices that the opening had already brought forth. 
The composition of the Coordination Group had stabilized after the first few meetings to representatives 
of 
• the Ministry of Health, which we here interpret as articulating the regulatory practices 
concerned with allocating costs and benefits within the healthcare system, 
• the drug committee of the federal association of physicians 
• the federal associations of hospital and community pharmacists,  
• an ‘action platform for patient safety’ which includes patient organizations but is dominated 
by healthcare professionals, 
• and of federal patient and nursing organizations. 
Thus, the group comprised five practices, namely those of regulators, physicians, pharmacists, patients, 
and nurses.  
There were two kinds of moves to claim ownership of the Medication Plan which we characterize as 
attempts at ‘appropriation’ in the following, namely, (1) proposals to restrict its purpose, and (2) 
proposals to limit the leeway users have in filling in medication data.  
The first type of appropriation gesture, proposals to restrict the purpose of the Medication Plan, aimed 
at positioning it primarily as a document for patients to help them comply with the instructions of 
physicians. Such proposals were successfully countered with the argument that the communication 
function of the Medication Plan is essential for improving medication therapy safety. The topic of these 
discussions was whether the Medication Plan should also include a 2D barcode. This barcode would 
facilitate communication between the various practices. For example, patients may also buy some Over-
The-Counter (OTC) drugs when presenting a prescription to a pharmacist. The pharmacist could then 
read the 2D barcode into her system, add the OTC drugs to the Medication Plan, check for possible 
undesired drug events, and print out the updated and validated Medication Plan. On his next visit to the 
physician, the patient would present the updated Medication Plan again so that the data entered by the 
pharmacist are now available to the physician too. This might include information about why the patient 
                                                      
4 It is interesting to note that the group maintained that distinction for a considerable time even after a European directive had 
re-defined undesired drug effects to include medication errors, a re-definition which effectively collapses the distinction 
between undesired drug effects and undesired drug events and which the group eventually incorporated into its glossary. 
However, even one year after the need for adapting to the European directive had been first discussed by the group, the group 
decided that a proposed project would only be funded if the distinction between undesired drug effects and medication errors 
is accepted and worked into the project proposal. Thus, the group maintained this distinction in the face of considerable external 
pressure to give it up. 
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has been dispensed the OTC drugs, thus facilitating a direct professional exchange between pharmacist 
and physician. 
On two occasions, participants expressly opposed this inclusion of the barcode as part of the Medication 
Plan, arguing that the purpose of the Medication Plan was primarily to instruct patients. Opposition to 
the 2D barcode was articulated by the representative of the Ministry of Health, who argued that 
dropping the barcode would avoid the necessity of equipping physician practices with scanners. Also, 
the representative of the hospital association was against inclusion of the 2D barcode in the Medication 
Plan, arguing that pursuing purposes other than instructing patients about the right way to take drugs 
would increase the barriers to its adoption. These two arguments reflect concerns about the ‘costs’ of 
implementing the Medication Plan in physician practices and hospitals. However, restricting the 
purpose of the Medication Plan to ensuring compliance by patients would have also strengthened a 
traditional understanding of the role of physicians as having complete authority over the medication of 
a patient. 
By fending off this closure gesture, the opening that had emerged in the initial meetings of the 
Coordination Group, as a potential re-orienting of the practices of pharmacist and physician, was kept 
open. This ‘keeping open’ did not just consist of rejecting a narrow understanding of the purpose of the 
Medication Plan, but also specified a way in which the professions involved in medication decisions 
might communicate with each other. This is significant since the traditional means of communication 
between physician and pharmacist, the prescription, does not allow for a ‘talking back’ of the 
pharmacist to the physician. Hence, fending off efforts to restrict the Medication Plan to a single purpose 
also helped to further clarify the relationship between physician and pharmacist and to elaborate the 
opening that had emerged as a potential re-orienting of these practice. 
The second appropriating move concerned various proposals to use coding systems for automatically 
filling in medication data. Instead of entering plaintext into a particular field, users would have to enter 
a code into software that would retrieve and fill the field contents from an appropriate database. The 
range of possible entries into a data field would thus be significantly constrained as compared to a 
plaintext field. Specifically, pharmacists proposed to use codes for, among others, the fields ‘active 
ingredient’, ‘suggestions for taking a particular drug’ (e.g. ‘before the meal’), and ‘reason for taking a 
particular drug’ (e.g. ‘against high blood pressure’). The first field, ‘active ingredient’, concerns the 
relationship between pharmacist and physician, the second and third fields the relations between 
pharmacist, physician, and patient. 
The proposal to use codes for the field ‘active ingredient’ were related to a prominent project located 
in East Germany. There, a different form of re-orientation between the professions of pharmacists and 
physicians was proposed and tried out. This project was initiated by the federal association of 
pharmacists, which is also an institutional member of the Coordination Group, and the federal 
association of panel physicians, which was often present as a guest in the Coordination Group meetings 
before becoming a regular member. The most important element of this project was an agreement that 
physicians only prescribe so-called active ingredients, the chemical substance that causes the intended 
as well as the unintended effects of a drug in the human body, and pharmacists then select the 
appropriate drug.5 Within the East German project, a complex choreography of interactions between 
the physician and the pharmacist was designed that would produce a medication plan which reflected 
their joint decision making, which is then handed over to the patient. The two projects are thus similar 
but also distinct. The Medication Plan, as envisaged by the Coordination Group, is (also) a 
communication tool for pharmacist and physician; by contrast, the medication plan as envisioned in the 
East German project is seen as the result of such communication. Moreover, as part of that project the 
roles of physician and pharmacist are precisely defined and their communication is precisely 
choreographed. This vision would have transformed the Medication Plan into a mechanistic form of 
communication – a coordination mechanism. As such this vision would have threatened the Medication 
Plan as the site of an opening where new forms of orienting the practices involved could continually be 
discovered and tried out. While the Coordination Group did not thematise advantages and disadvantages 
                                                      
5 Drugs whose patent protection has expired are normally offered by several manufacturers. These drugs differ in price but 
also in composition concerning additives and other substances, and probably in quality as well. 
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of the East German model, it rejected the proposal to use a coding system for filling the data field ‘active 
ingredient’ on the grounds that no mature coding systems are available for that purpose, thus fending 
off the possible ‘closure’ that would have resulted from bringing the medication plan idea under the 
influence of the East German project.  
Proposals, also by pharmacist members of the Coordination Group, to use codes for the fields 
‘suggestions for taking a particular drug’ and ‘reason for taking a particular drug’ were also rejected 
because of concerns about possible misinterpretations of these codes, especially by patients. The 
requirement that the contents of the medication plan must be intelligible to patients was emphasized 
several times in the context of discussing the use of codes. The group decided to use plaintext for these 
two fields in order to prevent any kind of ‘wrong interpretation’ until sufficient feedback from real-life 
tests had evaluated whether codes are helpful for users. Through this rejection, the group thus made it 
clear that patients are to be involved as active users of the medication plan, without specifying what 
‘active use’ really means. By fending off the interests of professionals, pharmacists in this case, the 
group came to assign a positive role to patients as users of the medication plan. 
We interpret these moves and counter-moves as an ongoing, dialectical working out of the opening. 
Efforts to appropriate the Medication Plan exclusively as an instructional device to ensure compliance 
by patients and as a tool to enforce a legalistic and technical version of medication management were 
fended off. These counter-moves, however, also produced a more nuanced picture of how the 
Medication Plan could function in a new form of interaction between the practices of physicians, 
pharmacists, and patients, while continuing to resist specifying how this interaction should or must look 
like on each occasion. Hence, the opening was kept open in these discussions and this also elaborated 
the re-orienting of the various practices involved. 
How the Opening was Kept Productive 
In this section, we document how, as the Medication Plan was tested, distinctions characterizing the 
involved practices came to the fore that had been glossed over in prior discussions. Articulation of these 
distinctions led to a further elaboration of the re-orienting of practices involved in medication. 
Moreover, as the Medication Plan was thematised in practice, the concern out of which it emerged was 
also elaborated. 
Projects to test the Medication Plan were announced along with the publication of the concept itself 
after the eighth meeting; however, the first test results were thematised only about five years later. As 
of October 2016, general practitioners are legally obliged to prepare and print a medication plan for 
patients who regularly take three or more prescription drugs, and as of April 2017 such medication 
plans have to be compliant with the specification of the Medication Plan published by the group, 
including the specifications for the 2D barcode. 
A continuing theme throughout the discussions of the group relating to these tests concerned problems 
with the various coding systems for automatic data filling. While the group rejected proposals to use 
such coding systems for several fields, as described above, four fields can be filled automatically by 
drawing on a code system for drug names known as the ‘PZN’ which emerged in the 1970s and is 
maintained jointly by trade associations of pharmaceutical manufacturers, wholesalers, and community 
pharmacies (Wagner, 2005). The PZN code acts as a data key for retrieving further drug-related 
information from commercially operated databases, including the trade name of the drug as registered 
with the authorities, the name of the active ingredient, the pharmaceutical form (e.g. tablet or a liquid), 
and the quantity of the active ingredient in one unit. A further field concerns the medication schedule, 
when to take each unit of the medicine. 
When creating a Medication Plan, a physician or a pharmacist could use their computer system to 
retrieve drug-related data from the databases of several data providers using the PZN as a key.6 
                                                      
6 While the ‘e-health law’ later specified that only physicians are obliged to create and print out a Medication Plan, earlier 
discussions in the group show that the group also envisaged that pharmacists can create and print a Medication Plan for patients. 
Presently, the role of pharmacists in creating and updating the Medication Plan has not yet become clear. 
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However, field tests consistently showed that there are differences between data providers in how such 
data are maintained, especially the ‘active ingredient’ and ‘pharmaceutical form’ but also the ‘trade 
name’ fields. As a result of these inconsistency, the contents of the Medication Plan may change when 
it is scanned compared to when it is printed out again, even though the medication itself did not change. 
While in their discussions of these problems the members of the Coordination Group were mostly 
concerned with the costs of making the various data sources consistent, the discovery of these 
inconsistencies was also productive. For example, the group decided to design their own classification 
system for pharmaceutical forms. This move was heavily criticized by the three main database providers 
who feared damage to their businesses. They meanwhile cooperated to make their own classification 
systems for the pharmaceutical form of drugs consistent. However, the Coordination Group decided 
that it would continue to maintain and make available its own classification system, arguing that 
contents used in the Medication Plan should be in the public domain. More importantly, the group also 
argued that all contents of the Medication Plan must be intelligible to patients, an argument that had 
been made in other contexts as well, as reported above. Thus, the discovery of these data inconsistencies 
also contributed to a further elaboration of the re-orienting of the practices involved in medication 
processes by reasserting the active role of patients in its use. 
While most tests of the Medication Plan involving patients concerned questions of usability and 
legibility, a project of the Aachen Learning Community, in which one of the authors is actively 
involved, studied how the Medication Plan changes the relations of the various practices by conducting 
reflective video conversations with patients, pharmacists, and physicians. One finding from these 
conversations is noteworthy. It became clear that the Medication Plan can become an occasion to bring 
into view the medication of a patient as a whole. This was most clearly articulated by a diabetes patient, 
but also by the physician member of the Learning Community. The patient reported how the Medication 
Plan had enabled thematising her medication holistically in both her interactions with her physicians 
and her pharmacist. The most striking incidence of this concerned her interaction with a neurologist. 
He had refused to create a Medication Plan for her on the grounds that he was not her family doctor. 
However, talking about the Medication Plan led him to review her medication, subsequently finding a 
medication error. Thus, the talk about the Medication Plan seems to have changed the way that he views 
or comports to the medication, namely now in a more holistic manner. A Medication Plan was 
eventually created and printed by her endocrinologist. This also included the medication prescribed by 
the other physicians (about 6) she regularly sees as well as OTC drugs. Her pharmacist then spent about 
half an hour going through the Medication Plan again. Both, her family doctor and her pharmacist had 
initially responded rather negatively to her request to prepare and check her medication plan but then 
became rather enthusiastic about this. Overall, she feels that her medication has acquired a new quality 
– that of being reviewed and approved holistically - even in cases where the medication was not 
changed. Moreover, her family doctor began to be concerned with the way she takes certain drugs and 
has asked her to visit more often to follow up on her medication-taking practice. The patient described 
this as ‘reining in’ her drug taking practice, something that was not entirely unwelcome to her. 
The physician member of the Aachen Learning Community confirmed these observations that the 
Medication Plan provides an occasion to concern oneself more intensively and holistically with the 
medication of a patient. In particular, he noted (our translation): 
My experience is that the correct filling-in of the Medication Plan requires a lot of work, a lot 
of thinking through; it also occasionally forces the physician to check whether everything 
written down there [on the Medication Plan] is still up-to-date, is it still necessary? On the other 
hand, it is an instrument which calls for a lot of dynamic, because the Medication Plan is 
normally valid only for a few weeks or months and is then changed and modified again, and 
this, on each occasion, requires a new thinking through of the plan and the medication. Of 
course, not everything will be changed, but everything must be critically evaluated, and this is 
an important process. 
He also believes that the Medication Plan is important for both physician and patient. In addition, he 
sees a need to comply with regulatory intentions. 
BIS WP2017-01 Living Infrastructure 
 
We interpret these experiences as showing that the Medication Plan is ‘generative’ in the sense that, in 
practical use and testing, it continues to generate discussions and discoveries, resulting in further re-
orienting of the practices involved in medication as the opening is further elaborated. This elaboration 
results from an ongoing practical interpretation of the Medication Plan such that, as its possible uses 
and purposes come to be better understood, each participant also comes to understand their own practice 
better and in a more nuanced way. 
Discussion 
In this section, we will interpret the happening of an opening, revealed by the Medication Plan case 
above, as a dialectic process of opposing proximity and distance between the practices as regions of a 
concern. This overarching dialectic of nearness and farness can be analysed into three constituent 
dialectics, namely, between the already familiar and the not yet familiar, between the self and the other, 
and between resistance and accommodation. Each dialectic powers an aspect of the overall happening 
of an opening and we will describe these sub-processes in the following sub-sections. To bring out how 
and why these dialectical processes can be productive, we will also describe how the delicate balance 
of nearness and farness in each is in constant danger of being closed down. 
Recursive Processes in an Opening 
The dialectic of the already familiar and the not yet familiar is the most fragile and hidden of the three 
dialectics. It involves a recursive process because it is powered by the anticipation of a possibility which 
has not yet become manifest, but which must still be assumed to be sufficiently solid to become the 
basis for concrete action and to manifest itself as something familiar. For example, for the Medication 
Plan to be able to become a site of an opening, the members of the Coordination Group had to allow a 
possible reality for the Medication Plan to structure their discussions and thus, in a sense, to create the 
foundations for its own coming into existence. Consequently, there was a high risk that such intuitive 
action would not live-up to the expectations of participants or that it was ill-founded. As well as being 
productive this process creates a particular vulnerability and fragility of the opening as well. 
The danger which constantly threatens to break the productive tension inherent in this recursive process 
is not that people refuse to allow a possible reality into their discourse – this may be the case, but would 
simply signify a lack of imagination – but rather, that the possible reality that announces itself in such 
discourse is seen merely as a ‘token’ for some intentions that cannot or should not in fact be expected 
to become actual. In other words, a rift is created between present reality and a purely symbolic world 
that cannot be bridged. In our example, that danger could have manifested in a discourse about the 
Medication Plan characterized by an expectation that the Medication Plan will never acquire any real 
meaning, even if used in practice. This would amount to the discussion acquiring such a token character. 
This danger of tokenization was ever present, not only in the initial discussions, but also throughout the 
testing of the Medication Plan and in its everyday use. Conversely, the opening for which the 
Medication Plan has become a site continues to be productive only if, throughout its conception and 
everyday use an as yet unknown and unfamiliar reality is allowed to structure the conversations about 
the Medication Plan and inform ways of using it. Since this recursive process accounts for the ‘taking 
hold’ of an opening, it follows that the taking hold is not a singular event after which an opening ‘exists’, 
but part of the ongoing becoming of the opening, and that there is an ever present danger that relations 
between practices may become unproductive and the opening disappears.  
Assertive Processes in an Opening 
An opening is also at risk from efforts to take over control over it – to appropriate it. For example, 
pharmacist members in the Coordination Group have repeatedly attempted to transform the character 
of the Medication Plan into a primarily pharmaceutical document through proposals to add various 
fields that are especially important from a pharmaceutical perspective. Likewise, members of the 
pharmacist and the regulatory practices have attempted to transform the Medication Plan into a 
coordination mechanism by proposing a detailed choreography of interactions between pharmacist and 
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physician which would impose a narrow technical understanding of medication processes on 
physicians. Such efforts, however, were opposed by other members and eventually fended off.  
The interplay between appropriation moves and assertive countermoves are the manifestation of another 
kind of process at work in the happening of an opening. Again there is a dialectic at work here because, 
while counter-actions mainly served to keep practices from dominating or ‘colonizing’ the Medication 
Plan as the site of the opening, they also contributed to the further working out of the relationships 
between the various practices. Such assertive processes are thus powered by a productive opposition 
between ‘oneself’ and ‘the other’. They are productive to the extent that engagement with the other not 
only contributes to a better understanding of the other but also to a better understanding of one’s own 
role and possibilities. The danger is that the opening becomes ‘colonized’ by one practice that imposes 
its way of understanding and acting on the other practices to such an extent that there is no openness to 
alternate perspectives. 
Performative Processes in an Opening 
There is a third process in the happening of an opening which is highly significant for its productivity. 
It is powered by a dialectical encounter between the materiality of the site of the opening and the human 
agency of the practitioners.  For example, in field tests it was discovered that certain medication 
schedules could not be captured by the Medication Plan. Such discoveries, however, were not 
interpreted as uncovering deficiencies in the ‘design’ of the Medication Plan that should and could be 
eliminated by re-designing the Medication Plan as an artefact. Rather, they were performed in 
subsequent actions as disclosing further meaningful distinctions that needed somehow to be addressed. 
Tellingly, the Coordination Group appreciated the existence of more complex medication regimes while 
also resisting calls for re-designing the Medication Plan to capture such medication regimes more 
mechanically. Other examples concern the practical interactions of physicians and pharmacists with the 
Medication Plan, which led them to change their comportment toward it and to understand the 
medication of their patients in a more holistic manner. 
We interpret such discoveries as resulting from a performative dialectic of resistance and 
accommodation in interactions between human agency and a certain ‘material agency’ of the site of the 
opening, as described by Pickering’s mangle of practice concept (1995). For instance, when interacting 
with the Medication Plan, one does not just encounter a certain material artefact, but all the other 
practices involved in medication processes in a performative manner. Such encounters with the 
resistance offered by the site of the opening may thus be experienced as a form of ‘practice resistance’ 
(Johnston, Reimers and Klein, 2016) that calls into question or renders problematic certain aspects of 
one’s own interpretations and understandings. By accommodating to such resistance by adjusting one’s 
understanding and way of acting, the relationships between the various practices are further refined and 
elaborated. This dialectic is, therefore, also productive. The danger consists in reconciling such 
discrepancies in a mechanical manner, for example, by re-designing the Medication Plan to 
accommodate every variation that occurs in practice. Another form of ‘mechanizing’ the Medication 
Plan would be to prescribe ways of interacting through it so tightly that human agency is entirely 
deleted, as envisioned by the East German project. In both kinds of mechanization, a seemingly 
straightforward mechanical ‘solution’ to an existing ‘problem’ would be ‘implemented’: the result 
would be to close down an ‘opportunity’ to disclose new meaningful distinctions that support more 
nuanced productive relations between the practices. 
 
In sum, the nature of an opening consists in a certain way of re-orienting the various practices to one 
another which is productive. Three dialectics are at work in this re-orienting: a recursive dialectic that 
allows an opening to take hold, an assertive dialectic that keeps multiple perspectives in play, and a 
performative dialectic the keeps the opening productive. Each dialectic process is powered by a distinct 
opposition at work among practices, namely, between the already familiar and the not yet familiar, 
between self and other, and between resistance and accommodation. As such, they are each aspects of 
a more general dialectic of nearness and farness. Together these dialectics hold the practices apart as 
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distinct and autonomous regions of a concern, and at the same time, provide a site where creative 
tensions and new meaningful distinctions are kept in play through close productive interaction.  
Conclusion 
We set out to elaborate the notion of ‘living infrastructure’. We drew on the example of the Medieval 
European City Square to suggest what a living infrastructure might consist of, and what might justify 
the adjective ‘living’ to distinguish it from traditional conceptions of infrastructure. The key idea is the 
notion that a living infrastructure becomes the site where an opening between certain regions of life, 
that share some concern, happens. This happening of the opening is an on-going process of nurturing 
and safeguarding certain productive oppositions between the regions of living that are at once recursive, 
assertive and performative in the sense developed in the previous section. 
We then presented an empirical case of the Federal Unified Medication Plan for medication therapy 
safety in the German healthcare environment. By a careful interpretation of the case materials we 
sharpened our conceptual tools and showed that this Medication Plan provides a site where a productive 
opening happens between multiple practices involved in medication processes in pursuit of a common 
concern for medication therapy safety. Thus, like the City Square, the Medication Plan exemplifies our 
notion of living infrastructure, as displayed in Table 2.  
Finally, we should briefly return to our comments at the beginning of the paper about the traditional 
conception of infrastructure as a material coordination system and relate them to the notion of living 
infrastructure. We will simply note, as discussed in the previous section, that when an infrastructure 
becomes tokenized, colonized or mechanized the productive tension between the regions of life lived 
there closes down. The infrastructure is no longer a site that holds open practices as distinctive and 
productive regions of life lived to the full: at most, only a mere material coordination mechanism for 
coordinating the transactional elements of existence remains.  
Table 2. Our conceptual framework, the City Square and the Medication Plan compared 
 
Concept Definition Examples 
The City Square The Medication Plan 
Concern A concern defines that aspect 
of human existence with 
which the infrastructure deals 
The concern is living a good life in 
a city 
The concern is medication 
therapy safety 
Region Regions are distinct aspects 
of the concern – they are 
distinct ‘locations on a map’ 
of the concern.  
The regions are the institutions of 
town life – religion, state, 
commerce, and education/culture 
The practices involved with 
medication – medical, 
pharmaceutical, patienthood, 
regulatory 
Opening An opening is the 
establishment of productive 
distinctions between the 
regions of the concern 
The establishment of distinctions 
between spiritual, corporal, 
individual and social aspects of a 
good city life 
The establishment of productive 
relations between distinct 
practices involved in medication 
processes 
Site of an 
opening 
Where an instance of an 
opening takes hold 
The lived-in city square that 
provides the conditions of an 
opening between church, town hall, 
market and school to happen 
An actual in-use medication plan 
sustains a productive opening 
between physician, pharmacist, 
patient, and regulator/insurer 
The 
happening 
of opening 
How an opening arises, is 
kept open, and continues to 
be productive  
The city square as an opening 
happens through various on-going 
dialectical processes, which could 
be documented for any particular 
city square 
The Medication Plan as an 
opening happens by: taking hold 
through a dialectic of the already 
familiar and the not yet familiar; 
being held open through a 
dialectic of self and other; and 
remaining productive through a 
dialectic of resistance and 
accommodation 
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